In a country where the vitality of the president tends to serve as a proxy-in for credibility as a leader, President Donald J. Trump — now in his second term and the oldest president to hold office in U.S. history — is again making cognitive health the focal point of the nation's dialogue. Speaking on board Air Force One headed to West Palm Beach, the 78-year-old commander-in-chief made a public proclamation that he had "got every answer right" on a cognitive test administered during his annual check-up at Walter Reed Medical Center. "Good heart. Good soul. I felt I was in very good shape," said Trump, continuing that he went out of his way to take the test as a way of distinguishing himself from political rivals.
But what is this mental test actually — and what does it really tell us about a sitting president's mental acuity, particularly in the tough and high-wire job of Commander-in-Chief?
The president addressed openly to journalists on board during the trip to his home in West Palm Beach, Florida, assertively declaring, "I got every answer right." This comment has once again sparked public curiosity regarding the nature and importance of cognitive testing, particularly among aging political figures.
"I’m in very good shape — good heart, good soul, very good soul," President Trump told the White House press pool, emphasizing his physical and mental wellness. Not only did he point out the good results of his physical, but he also used the opportunity to differentiate himself from his political peers by mentioning that he took a cognitive test voluntarily — something he says his predecessors, former President Joe Biden and Vice President Kamala Harris, had declined to do.
This is not the first time President Trump has boasted about his cognitive abilities. In his last term, he made similar claims, even reciting memorable parts of the test like the now-famous phrase- "Man, Woman, Person, Camera, TV."
Former US President Donald Trump has been declared "fully fit" to serve as Commander-in-Chief, according to his latest physical examination report released by the White House on Sunday. The announcement comes at a time when the health of political leaders is under increased public scrutiny, especially in the United States.
The report holds particular significance as Trump remains the oldest individual ever elected to the presidency. One of the key highlights of the medical update is the noticeable reduction in his weight. Trump now weighs 224 pounds, down from 244 pounds during his previous physical in 2020. This 20-pound weight loss has also improved his Body Mass Index (BMI), lowering it from 30.5- which placed him in the "obese" category- to 28.0, categorizing him as "overweight."
According to his physician, this progress can be attributed to a more active and health-conscious lifestyle. The updated health report not only reflects improvements in Trump’s physical condition but also reinforces the broader national conversation around wellness and fitness in American political leadership.
The test in question is the Montreal Cognitive Assessment (MoCA), a standardized screening tool developed in 1996 by neurologist Dr. Ziad Nasreddine. It’s widely used to detect mild cognitive impairment and early signs of Alzheimer's disease. Despite its simplicity for cognitively healthy individuals, the test is a powerful tool in neurological diagnostics.
MoCA tests several areas of brain function such as memory, attention, language, visuospatial abilities, and executive functions. It takes about 10 minutes and is commonly utilized by neurologists and primary care physicians to screen for cognitive impairments in persons aged 65 years and older.
President Trump claimed that he got every question correct — and for a cognitively healthy person, that is what is expected. But what is the MoCA, and are its last questions as hard as Trump claims?
The test starts with a series of drawing exercises that involve:
These exercises assess spatial knowledge, attention, and planning abilities — tasks that can decline with age or neurological deterioration.
These are illustrated animals — often a lion, camel, and rhinoceros — and participants are requested to identify them. This task appears straightforward but can be sensitive to problems with recall of language or semantic memory.
One of the more difficult sections of the test is when subjects are required to recall a series of five unrelated words. Later in the test, they are required to recall these same words without cues. This delayed recall section often uncovers early memory lapses.
In the following section, items involve the repetition of strings of numbers forward and backward and simple subtraction items (e.g., subtract 7 from 100 consecutively). This assesses working memory and attention.
Here, the subjects are required to say as many words as possible beginning with the letter "F" within 60 seconds. Subsequently, they have to describe similarities of two things — for example, how a train and a bicycle are similar (both are means of transport).
The last section of the test tests an individual's sense of time and place — requesting that the subject give the present date, day of the week, month, year, and place.
When asked about the difficulty of the test, Trump said, "I'll bet you couldn't even answer the last five questions. They get very hard." While certain sections, such as delayed recall and abstraction, may be challenging for people with early indicators of cognitive impairment, experts explain that the test is not intended to be excessively difficult for non-impaired individuals.
"The MoCA is not a test of intelligence," explains Dr. Sarah Williams, a Johns Hopkins Medicine neurologist. "It's intended to screen for very subtle indicators of cognitive decline. If you are cognitively normal, it will be very easy."
Trump's insistence on taking cognitive testing is less about boasting rights — it is also a sign of larger public anxieties surrounding aging leaders and their cognitive abilities. With both leading presidential candidates now over their late 70s and early 80s, mental sharpness issues have become an overarching theme in American politics.
Trump’s repeated willingness to undergo and publicize the results of cognitive testing could be interpreted as a strategic move to address those concerns head-on. “The American people want a mentally sharp president,” he said. “I think I’ve proven that.”
Source: Parkland Fire Company
A Pennsylvania nursing home caught on fire due to an apparent gas explosion. The Silver Lake Nursing home in Pennsylvania's Bristol Township caught on fire, and videos show flames erupting from the building, and debris scattered around the area. The Pennsylvania Governor Josh Shapiro confirmed the that there are so far two deaths, with 21 people found injured. Many have been rescued, yet rescuers believe that five people are unaccounted for.
At 2.15pm is when the flames could be seen from the gas-related explosion. PECO confirmed that crew had started to respond around 2pm itself after they received reports of a gas odor. The explosion had occurred when the crew were on the scene.
“While crews were on site, an explosion occurred at the facility. PECO crews shut off natural gas and electric service to the facility to ensure the safety of first responders and local residents,” the utility said in a the statement.
State Rep. Tina Davis told the Associated Press. "I saw smoke and I saw car after car after car was a fire truck or ambulance from all over the city, from all over."
Davis says that there were talks of using a nearby school as a temporary evacuation area.
Burn injuries are first classified before the treatment. Their classification decides the treatment the burn will require. There are for classifications of burns:
First-degree or superficial burns: They only affect the outer layer of the skin or the epidermis. In these injuries, the burn site is red, painful, dry, and has no blisters.
Second-degree or partial thickness burns: They are only the burns of epidermis and part of the lower layer of the skin, the dermis. The burn site looks red and blistered and may be swollen and painful.
Third-degree or full thickness burns: Third-degree burns destroy the epidermis and dermis. They could also go to the innermost later of the skin, the subcutaneous tissue. The burn site could look white or blackened and charred.
Fourth-degree burns: They burn through both layers of the skin and underlying tissue as well as deeper tissue, and could possibly reach muscle and bone. There is no feeling in the area since the nerve endings are destroyed.
The right way to treat a burn depends on its depth and how much of the body it covers. While minor, superficial burns can be managed at home, deeper or larger burns may need medical attention. Keep these essential guidelines in mind:
Credits: Canva/AP
Former Senator Ben Sasse shared on Tuesday that he has been diagnosed with Stage 4 pancreatic cancer. The former two-term senator, now 53, revealed in a long social media message that he learned about the illness last week. “This is a hard note to write, but since many of you have already sensed something, I’ll get straight to it: Last week I was diagnosed with metastasized, stage-four pancreatic cancer, and I am going to die,” Sasse wrote. He went on to describe advanced pancreatic cancer as “brutal” and called it a death sentence, adding that mortality is something everyone carries.
“I’m fortunate to have incredible siblings and half a dozen friends who are truly like brothers to me. As one of them said, ‘Yes, you’re on the clock, but all of us are.’ Death is a cruel thief, and none of us escape it,” he added.
The Nebraska Republican also wrote, “I’ll have more to share. I’m not giving up without a fight.”
Former senator and former University of Florida president Ben Sasse announced on Tuesday, Dec. 23, that he has been diagnosed with terminal stage 4 cancer, as per CNN News.
In the deeply personal message, the former Republican lawmaker from Nebraska described the diagnosis as a “death sentence,” while expressing appreciation for the steady support of his family and close friends.
Stage 4 pancreatic cancer, also known as metastatic pancreatic cancer, means the disease has spread beyond the pancreas to distant organs such as the liver, lungs, or the lining of the abdomen. At this advanced stage, the cancer is generally considered incurable, and care focuses on prolonging life and easing symptoms like pain, weight loss, and jaundice through palliative treatment, with the goal of preserving quality of life, as per Cleveland Clinic.
Pancreatic cancer has a far poorer survival outlook than prostate cancer, largely because it is usually detected late and has fewer effective treatment options. Most men diagnosed with prostate cancer that has not spread survive at least five years, while pancreatic cancer is often found at an advanced stage, where long-term survival is uncommon.
According to the American Cancer Society, pancreatic cancer makes up about 3 percent of all cancers in the United States but accounts for roughly 8 percent of cancer-related deaths. Most patients are diagnosed at Stage 4, and the disease is widely regarded as largely incurable. Prostate cancer, by contrast, is the second most common cancer among men, and the majority of those diagnosed do not die from it. The five-year relative survival rate for non-metastasized prostate cancer is 97.9 percent, dropping to about 38 percent once it spreads. These figures highlight how early detection and effective treatment options make prostate cancer far more survivable than pancreatic cancer.
Recent news has included diagnoses such as Ben Sasse’s terminal pancreatic cancer, as well as public figures like John Eimen, who died from prostate cancer. These cases draw attention to the difficulty of detecting pancreatic cancer early, since there are few reliable screening tools before symptoms appear. Prostate cancer, in contrast, often progresses slowly, and with regular screening and multiple treatment options, many men live for decades after diagnosis.
While treatments including chemotherapy, radiation, and in rare situations surgery are available, stage-four pancreatic cancer is still considered largely incurable. The absence of effective early screening contributes to delayed diagnosis, and although a small number of patients, such as Ruth Bader Ginsburg, have lived longer following surgery, these cases are rare. Well-known individuals including Alex Trebek and Aretha Franklin also battled the disease, which remains one of the deadliest cancers in the United States.
Credits: Canva
Union Minister of State (Independent Charge) for Science and Technology and Earth Sciences, along with responsibilities in the PMO, Personnel, Public Grievances, Pensions, Atomic Energy, and Space, Dr Jitendra Singh on Tuesday called for careful and evidence-led use of anti-obesity and weight-reduction medicines. He stressed that these drugs should be prescribed thoughtfully and not treated as routine or easy solutions.
Addressing the inaugural session of the Asia Oceania Conference on Obesity (AOCO), the minister said obesity is a complex, long-term condition that tends to recur and cannot be managed through isolated medical treatment alone. Instead, he said, it needs a wider response involving society at large.
At the same event, Dr Singh also launched the National Obesity Registry, describing it as an important step towards strengthening India’s obesity research framework. The initiative aims to support structured data collection, generate reliable evidence, and guide long-term policymaking in the area.
During the conference, Dr Jitendra Singh formally unveiled the AIAARO Obesity Registry, calling it a major move to strengthen India’s research ecosystem. The registry will focus on systematic data collection, long-term follow-up, and evidence-based policymaking. It is expected to help improve clinical understanding of obesity and support the development of national strategies for its management.
India’s National Obesity Registry (NOR), launched in December 2025, is designed to create a strong and reliable data base on obesity trends across the country. This data will support public health policies, research efforts, and targeted interventions to address the growing obesity burden. The initiative is particularly significant for India, given its unique challenges related to metabolic obesity and its strong links with non-communicable diseases.
While launching the registry, Dr Singh also highlighted the strong focus placed by Prime Minister Narendra Modi on tackling lifestyle-related illnesses. He noted that the Prime Minister has repeatedly spoken about obesity on national platforms, reflecting a clear shift towards preventive healthcare. This approach, he said, is supported by initiatives such as FIT India, Khelo India, and programmes that encourage small but lasting behavioural changes.
The minister warned against the increasing commercialisation of obesity treatment and the spread of misinformation in this space. Referring to a PIB release, he said unscientific claims and so-called quick solutions often mislead people and divert attention from treatments backed by medical evidence.
India has seen a growing use of injectable obesity treatments such as Wegovy and Poviztra, both based on semaglutide, and Yurpeak, which uses tirzepatide. These once-weekly injections work by mimicking gut hormones that help regulate appetite and are marketed by companies like Novo Nordisk and Eli Lilly. However, doctors caution that these drugs are not miracle solutions and must be combined with proper diet and physical activity. There are also concerns about their overuse at a time when obesity rates continue to rise.
According to the World Health Organisation, obesity was linked to 3.7 million deaths globally in 2024. If strong action is not taken, the number of people living with obesity is expected to double by 2030. Recently, the WHO released its first-ever guideline on the use of Glucagon-Like Peptide-1, or GLP-1, therapies for managing obesity as a chronic and relapsing condition.
“Obesity is a major global health challenge that WHO is committed to addressing by supporting countries and people worldwide to control it effectively and equitably. Our new guidance recognises that obesity is a chronic disease that can be treated with comprehensive and lifelong care,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus.
© 2024 Bennett, Coleman & Company Limited